Flotufolastat F 18 (Posluma)
Optional dilutionFull monograph review pending
U.S. label preparation
Posluma · Optional dilution
- Preparation
- Optional dilution for this PET radiopharmaceutical uses 0.9% sodium chloride. The maximum recommended undiluted injection volume is 5 mL.
- Administration and handling
- Confirm activity in a dose calibrator and use the labeled radiation shielding.
Product and source details
Blue Earth Diagnostics · NDA216023
Product NDC: 69932-002
SPL effective 2026-07-25 | SPL version 11. Checked 2026-11-13.
Source for this summary: U.S. prescribing information. Use the full label for dose selection, contraindications, preparation tables and monitoring.
Product identifiers and clinical review status
U.S. label preparation available. Full monograph review pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Obtain independent corroboration of the label preparation where available.
- Complete indication- and age-specific dosing, incompatibility, monitoring and stability review.
- Assess any proposed compounding BUD for the exact formulation, concentration, container and conditions.